Page 78 - Immunization Practices News Today

A federal advisory panel recommended the new shot to be given to babies during or entering their first RSV season, similar to how a vaccine works.

The Centers for Disease Control and Prevention (CDC) officially recommended the first preventive Respiratory syncytial virus (RSV) treatment for infants on Thursday, shortly after a key panel endorsed the product. CDC Director Mandy Cohen adopted the guidance recommended by the Advisory Committee on Immunization Practices (ACIP) on Thursday for the administration of nirsevimab, or Beyfortus.…

By Cecilia Butini Sanofi and AstraZenecas preventative treatment for respiratory syncytial virus was recommended for use by an independent health expert body advising the U.S. Centers for...

A panel of independent experts voted unanimously to recommend the treatment to protect infants from the lung-infecting virus.

A panel of independent experts voted unanimously to recommend the treatment to protect infants from the lung-infecting virus.

The Inflation Reduction Act includes several provisions that will lower prescription drug costs for people with Medicare and reduce drug spending by the federal government. This brief summarizes these provisions and discusses the expected effects on people, program spending, and drug prices and innovation.

The US Centers for Disease Control and Prevention (CDC) said its advisory panel on Thursday recommended use of Sanofi and partner AstraZenecas antibody therapy to prevent respiratory syncytial virus (RSV) in infants and toddlers.

BioPharma

The CDC has unanimously voted to recommend routine use of the anti-RSV monoclonal antibody Beyfortus to prevent RSV disease in infants.

The CDC is recommending a dose of the monoclonal antibody nirsevimab to protect against severe illness caused by RSV.